TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies May 2, 2003
TCL Archive NCAB Subcommittee Urges New Centers Categories, Recognition Of More New Comprehensive Centers March 28, 1975